DrugCite
Search

DIPRIVAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Diprivan Adverse Events Reported to the FDA Over Time

How are Diprivan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Diprivan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Diprivan is flagged as the suspect drug causing the adverse event.

Most Common Diprivan Adverse Events Reported to the FDA

What are the most common Diprivan adverse events reported to the FDA?

Anaphylactic Shock
280 (4.49%)
Hypotension
164 (2.63%)
Bronchospasm
132 (2.12%)
Delayed Recovery From Anaesthesia
123 (1.97%)
Rhabdomyolysis
122 (1.96%)
Cardiac Arrest
119 (1.91%)
Circulatory Collapse
97 (1.56%)
Shock
93 (1.49%)
Blood Pressure Decreased
90 (1.44%)
Propofol Infusion Syndrome
80 (1.28%)
Erythema
79 (1.27%)
Show More Show More
Bradycardia
76 (1.22%)
Tachycardia
70 (1.12%)
Aspartate Aminotransferase Increase...
68 (1.09%)
Metabolic Acidosis
61 (.98%)
Hyperthermia Malignant
60 (.96%)
Alanine Aminotransferase Increased
59 (.95%)
Blood Creatine Phosphokinase Increa...
58 (.93%)
Post Procedural Complication
58 (.93%)
Renal Failure Acute
58 (.93%)
Pyrexia
52 (.83%)
Rash
52 (.83%)
Oxygen Saturation Decreased
41 (.66%)
Respiratory Arrest
41 (.66%)
Generalised Erythema
40 (.64%)
Coma
38 (.61%)
Hepatic Function Abnormal
38 (.61%)
Ventricular Tachycardia
38 (.61%)
Cyanosis
36 (.58%)
Overdose
35 (.56%)
Procedural Complication
35 (.56%)
Urticaria
34 (.55%)
Cardio-respiratory Arrest
33 (.53%)
Convulsion
33 (.53%)
Liver Disorder
32 (.51%)
Anaesthetic Complication
31 (.5%)
Accidental Overdose
30 (.48%)
Anaphylactic Reaction
29 (.47%)
Haemodialysis
29 (.47%)
Cytolytic Hepatitis
28 (.45%)
Depressed Level Of Consciousness
28 (.45%)
Septic Shock
28 (.45%)
Renal Impairment
27 (.43%)
Cardiac Failure
26 (.42%)
Multi-organ Failure
26 (.42%)
Respiratory Failure
26 (.42%)
Ventricular Fibrillation
26 (.42%)
Arrhythmia
24 (.38%)
Disseminated Intravascular Coagulat...
24 (.38%)
Myocardial Infarction
24 (.38%)
Drug Ineffective
23 (.37%)
Hypersensitivity
23 (.37%)
Atrial Fibrillation
21 (.34%)
Brain Oedema
21 (.34%)
Laryngeal Oedema
21 (.34%)
Loss Of Consciousness
21 (.34%)
Blood Pressure Increased
20 (.32%)
Renal Failure
20 (.32%)
Anuria
19 (.3%)
Blood Lactate Dehydrogenase Increas...
19 (.3%)
Cardiomyopathy
19 (.3%)
Death
19 (.3%)
Hypoxia
19 (.3%)
Hypoxic Encephalopathy
19 (.3%)
Medication Error
19 (.3%)
Pulmonary Oedema
19 (.3%)
Arteriospasm Coronary
18 (.29%)
Atrioventricular Block Complete
18 (.29%)
Dyspnoea
18 (.29%)
Electrocardiogram St Segment Elevat...
18 (.29%)
Myoglobinuria
18 (.29%)
Pancreatitis Acute
18 (.29%)
Atrioventricular Block
17 (.27%)
Blood Amylase Increased
17 (.27%)
Cholestasis
17 (.27%)
Drug Interaction
17 (.27%)
Hyperkalaemia
17 (.27%)
Pancreatitis
17 (.27%)
Platelet Count Decreased
17 (.27%)
Respiratory Depression
17 (.27%)
Agranulocytosis
16 (.26%)
Altered State Of Consciousness
16 (.26%)
Pruritus
16 (.26%)
Condition Aggravated
15 (.24%)
Confusional State
15 (.24%)
Pancytopenia
15 (.24%)
Sepsis
15 (.24%)
Anaphylactoid Shock
14 (.22%)
Apnoea
14 (.22%)
Asthenia
14 (.22%)
Brain Death
14 (.22%)
Chills
14 (.22%)
Haematuria
14 (.22%)
Hyperhidrosis
14 (.22%)
Oedema
14 (.22%)
Ventricular Extrasystoles
14 (.22%)
Anaphylactoid Reaction
13 (.21%)
Cerebral Infarction
13 (.21%)
Dyskinesia
13 (.21%)
Face Oedema
13 (.21%)
Heart Rate Increased
13 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Diprivan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Diprivan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Diprivan

What are the most common Diprivan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Diprivan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Diprivan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Diprivan According to Those Reporting Adverse Events

Why are people taking Diprivan, according to those reporting adverse events to the FDA?

Sedation
391
Induction Of Anaesthesia
358
Anaesthesia
305
General Anaesthesia
278
Product Used For Unknown Indication
73
Induction And Maintenance Of Anaest...
70
Show More Show More
Drug Use For Unknown Indication
65
Maintenance Of Anaesthesia
47
Sedative Therapy
40
Anaesthesia Procedure
16
Surgery
15
Endoscopy
11
Colonoscopy
10
Insomnia
8
Status Epilepticus
8
Lung Transplant
6
Endoscopy Upper Gastrointestinal Tr...
5
Oesophagogastroduodenoscopy
5
Prophylaxis
4
Injury
4
Epilepsy
4
Arthroscopy
4
Partial Seizures With Secondary Gen...
4
Ventricular Tachycardia
3
Osteitis
3
Convulsion
3
Intracranial Pressure Increased
3
Respiratory Distress
3
Agitation
3
Light Anaesthesia
3
Endotracheal Intubation
3
Intubation
3
Epidural Anaesthesia
3
Pain
3
Postoperative Analgesia
3
Postoperative Care
3
Convulsion Prophylaxis
3
Femur Fracture
2
Nephroureterectomy
2
Abortion Induced
2
Reduction Of Increased Intracranial...
2
Cardiac Operation
2
Mechanical Ventilation
2
Unevaluable Event
2
In Vitro Fertilisation
2
Drug Toxicity
2
Postresuscitation Encephalopathy
2
Acute Myocardial Infarction
2
Hypotonia
2
Juvenile Arthritis
2
Glossectomy
2

Drug Labels

LabelLabelerEffective
DiprivanAPP Pharmaceuticals, LLC23-NOV-09
DiprivanGeneral Injectables & Vaccines, Inc06-MAY-11
DiprivanFresenius Kabi USA, LLC22-FEB-13

Diprivan Case Reports

What Diprivan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Diprivan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Diprivan.